The core technology behind Arbiter is adapted from pathogen detection in human health, with a technology partner providing the fluorescent tagging and nucleic acid reading capabilities. From UMAMI’s ...
Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...
VALENCIA, Spain, Nov. 11, 2024 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, today ...
Report Ocean has published a new report on the Saudi Arabia Immunohematology Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report ...
“We are thrilled to bring MI Cancer Seek to market to ensure patients have access to critical precision medicine tools.” The next-generation sequencing–based in vitro diagnostic device uses total ...
Shares of cannabis producer Canopy Growth fell after a slowdown in adult marijuana use in Canada weighed on earnings. Shares of Maravai LifeSciences tumbled after the provider of nucleic acid to life ...
Analysts were expecting a per-share loss of 4 cents. The company's operating loss widened in the quarter largely due to a $154.2 million goodwill impairment, which is related to the company's Nucleic ...